tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide

C137H157N37O17 — CID 158285075

IUPACtris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide
SMILESCn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCOCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2COCCO2)c2ccc(NC(=O)c3ncccc3N)cc21
InChIInChI=1S/C20H23N5O3.3C20H23N5O2.2C19H22N6O2.C19H21N5O4/c1-25-17-11-14(23-19(26)18-16(21)3-2-8-22-18)4-5-15(17)20(24-25)28-12-13-6-9-27-10-7-13;3*1-25-17-11-14(23-19(26)18-16(21)7-4-10-22-18)8-9-15(17)20(24-25)27-12-13-5-2-3-6-13;2*1-25-15-9-13(23-18(26)16-14(20)7-4-8-21-16)10-22-17(15)19(24-25)27-11-12-5-2-3-6-12;1-24-16-9-12(22-18(25)17-15(20)3-2-6-21-17)4-5-14(16)19(23-24)28-11-13-10-26-7-8-27-13/h2-5,8,11,13H,6-7,9-10,12,21H2,1H3,(H,23,26);3*4,7-11,13H,2-3,5-6,12,21H2,1H3,(H,23,26);2*4,7-10,12H,2-3,5-6,11,20H2,1H3,(H,23,26);2-6,9,13H,7-8,10-11,20H2,1H3,(H,22,25)
InChIKeyGKRIGDMQDMTJAD-UHFFFAOYSA-N
MW2594.00 g/mol
LogP19.85
Rot. Bonds35

About tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide

tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide (PubChem CID 158285075) has the molecular formula C137H157N37O17 and a molecular weight of 2594.00 g/mol. Its IUPAC name is tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide.

Molecular Properties

Compound Nametris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide
PubChem CID158285075
Molecular FormulaC137H157N37O17
Molecular Weight2594.00 g/mol
Exact Mass2592.26
IUPAC Nametris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide
SMILESCn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCOCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2COCCO2)c2ccc(NC(=O)c3ncccc3N)cc21
InChIInChI=1S/C20H23N5O3.3C20H23N5O2.2C19H22N6O2.C19H21N5O4/c1-25-17-11-14(23-19(26)18-16(21)3-2-8-22-18)4-5-15(17)20(24-25)28-12-13-6-9-27-10-7-13;3*1-25-17-11-14(23-19(26)18-16(21)7-4-10-22-18)8-9-15(17)20(24-25)27-12-13-5-2-3-6-13;2*1-25-15-9-13(23-18(26)16-14(20)7-4-8-21-16)10-22-17(15)19(24-25)27-11-12-5-2-3-6-12;1-24-16-9-12(22-18(25)17-15(20)3-2-6-21-17)4-5-14(16)19(23-24)28-11-13-10-26-7-8-27-13/h2-5,8,11,13H,6-7,9-10,12,21H2,1H3,(H,23,26);3*4,7-11,13H,2-3,5-6,12,21H2,1H3,(H,23,26);2*4,7-10,12H,2-3,5-6,11,20H2,1H3,(H,23,26);2-6,9,13H,7-8,10-11,20H2,1H3,(H,22,25)
InChIKeyGKRIGDMQDMTJAD-UHFFFAOYSA-N
XLogP19.85
TPSA718.89 Ų
H-Bond Donors14
H-Bond Acceptors47
Rotatable Bonds35
Heavy Atoms191
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002594.00
LogP ≤ 519.85
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1047

Analyze tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide?
The IUPAC name of tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide (CID 158285075) is tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide.
What is the SMILES notation for tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide?
The canonical SMILES for tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide is Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCCC2)c2ncc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2CCOCC2)c2ccc(NC(=O)c3ncccc3N)cc21.Cn1nc(OCC2COCCO2)c2ccc(NC(=O)c3ncccc3N)cc21.
What is the InChIKey of tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide?
The InChIKey is GKRIGDMQDMTJAD-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23N5O3.3C20H23N5O2.2C19H22N6O2.C19H21N5O4/c1-25-17-11-14(23-19(26)18-16(21)3-2-8-22-18)4-5-15(17)20(24-25)28-12-13-6-9-27-10-7-13;3*1-25-17-11-14(23-19(26)18-16(21)7-4-10-22-18)8-9-15(17)20(24-25)27-12-13-5-2-3-6-13;2*1-25-15-9-13(23-18(26)16-14(20)7-4-8-21-16)10-22-17(15)19(24-25)27-11-12-5-2-3-6-12;1-24-16-9-12(22-18(25)17-15(20)3-2-6-21-17)4-5-14(16)19(23-24)28-11-13-10-26-7-8-27-13/h2-5,8,11,13H,6-7,9-10,12,21H2,1H3,(H,23,26);3*4,7-11,13H,2-3,5-6,12,21H2,1H3,(H,23,26);2*4,7-10,12H,2-3,5-6,11,20H2,1H3,(H,23,26);2-6,9,13H,7-8,10-11,20H2,1H3,(H,22,25).
What are the key properties of tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide?
tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide has a molecular weight of 2594.00 g/mol, XLogP of 19.85, 35 rotatable bonds, 14 hydrogen bond donors, and 47 hydrogen bond acceptors.
Where does this data come from?
All data for tris(3-amino-N-[3-(cyclopentylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide);bis(3-amino-N-[3-(cyclopentylmethoxy)-1-methylpyrazolo[4,3-b]pyridin-6-yl]pyridine-2-carboxamide);3-amino-N-[3-(1,4-dioxan-2-ylmethoxy)-1-methylindazol-6-yl]pyridine-2-carboxamide;3-amino-N-[1-methyl-3-(oxan-4-ylmethoxy)indazol-6-yl]pyridine-2-carboxamide is sourced from PubChem (CID 158285075), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).